The expression of gonadotropin-releasing hormone (GnRH-I) and its receptor as a part of a negative autocrine/paracrine regulatory mechanism of cell proliferation has been demonstrated in a number of malignant tumors, including cancers of endometrium, ovary, and breast [7]. The gene discussed is GNRH1; the disease is cancer.